Edition:
United Kingdom

Aerie Pharmaceuticals Inc (AERI.OQ)

AERI.OQ on NASDAQ Stock Exchange Global Market

33.29USD
17 Jun 2019
Change (% chg)

-- (--)
Prev Close
$33.29
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
189,741
52-wk High
$74.75
52-wk Low
$31.01

About

Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's product candidates include Rhopressa (netarsudil ophthalmic solution) 0.02%... (more)

Overall

Beta: 0.63
Market Cap(Mil.): $1,456.51
Shares Outstanding(Mil.): 45.92
Dividend: --
Yield (%): --

Financials

  AERI.OQ Industry Sector
P/E (TTM): -- 103.12 37.45
EPS (TTM): -5.56 -- --
ROI: -83.13 7.69 12.16
ROE: -111.96 8.19 16.93

Earnings vs. Estimates